Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Alcoholic Liver Disease: Clinician Collaboration Needed to Encourage Abstinence
-
- 5 Weight Loss Procedures Featured at DDW
- Large Pancreatic Cysts: When to Operate, Whom to Involve John D. Christein, MD
- FDA Issues Recommendations for Development of DAAs for HCV
- Stivarga Increases Overall Survival in Patients with Unresectable HCC
- SYN-004 Shows Positive Results for Preventing C. difficile, Antibiotic-associated Diarrhea
- Our Call to Arms: HCV Kills More Than Any Other Infectious Disease
- The Patient with Metabolic Liver Disease
- WHO Issues Updated HCV Guidelines for Treatment
-
- CDC: More People Die of HCV Than any Other Infectious Disease
- Chromoendoscopy Effective for Surveillance in IBD Patients with History of Colorectal Dysplasia
- Few Infants with Reflux-like Symptoms Actually have GERD
- TOUCHSTONE: Ozanimod Shows Promise as Induction, Maintenance Therapy for UC
- Entyvio Most Effective for UC When Used as Early First-line Treatment
- Fatty Acid Linked to Increased Risk for UC Flare in Mesalamine-treated Patients
- Health Care Transition Readiness Lags in Pediatric EoE and EGE
- Low FODMAPs Linked to Altered Metabolome, Improved IBS Symptoms
-
- Many Childhood Celiac Patients do not Seek Follow-up Care as Adults
- VLE Predicts Complete Remission of Intestinal Metaplasia, Dysplasia in BE
- Seres Partners with Academic Groups for Development of Microbiome-based IBD Therapies
- White House Announces $121 Million Federal Investment in National Microbiome Initiative